Twinrix Hepatitis Vaccine Description
Twinrix is a bivalent vaccine containing the antigenic components used in producing HAVRIX (strain HM175) and ENGERIX-B [noninfectious hepatitis B virus surface antigen (HBsAg).].
The vaccine works by causing the body to produce its own protection (antibodies) against these diseases.
Twinrix Hepatitis Vaccine Indication
Twinrix is indicated for active immunization against disease caused by hepatitis A virus and infection by all known subtypes of hepatitis B virus.
Twinrix Hepatitis Vaccine Dosage
Twinrix is administered as an intramuscular injection. It is administered in a 3 dose series, at 0, 1, and 6 months.
Twinrix is approved for use in persons 18 years of age or older.